Torren Management’s Boston Scientific BSX Stock Holding History

Torren Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400	Closed	-$38.1K	–	1063
2025 Q4	$38.1K	Buy	+400	New	+$39.2K	0.02%	398

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Torren Management's BSX Position: Q1 2026 in Review

Torren Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 400 shares — an estimated $38.1K sold.

Torren Management first reported a position in BSX in Q4 2025 and held it in 1 quarter. The position peaked at $38.1K in Q4 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Torren Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Torren Management sold 400 Boston Scientific shares in Q1 2026, an estimated $38.1K.
Torren Management first reported a position in Boston Scientific in Q4 2025 and held it in 1 quarter.
Torren Management's Boston Scientific position peaked at $38.1K in Q4 2025.
1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.